Mostrar 1 - 8 resultats de 8 per cerca 'Lin-Yu Chen', hora de la petició: 0.07sec Refinar resultats
  1. 1
    A Director with Zeitgeist: Peking Opera Meets the Western Canon — Interview with Ma, Bao-Shan

    A Director with Zeitgeist: Peking Opera Meets the Western Canon — Interview with Ma, Bao-Shan per Lissa Tyler Renaud, Lin, Yu-Chen

    Publicat 2011-06-01
    Obtenir text complet
    Article
  2. 2
    The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes

    The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clin... per Lin-Yu Chen, Hsing-Yu Chen, Hung-Cheng Lai, Shiou-Fu Lin, Kuo-Chang Wen, Darmawi, Phui-Ly Liew

    Publicat 2025-01-01
    Obtenir text complet
    Article
  3. 3
    NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma

    NKX6-1 mediates cancer stem-like properties and regulates sonic hedgehog signaling in leiomyosarcoma per Po-Hsuan Su, Rui-Lan Huang, Hung-Cheng Lai, Lin-Yu Chen, Yu-Chun Weng, Chih-Chien Wang, Chia-Chun Wu

    Publicat 2021-04-01
    Obtenir text complet
    Article
  4. 4
    Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway

    Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway per Ayon A. Hassan, Margarita Artemenko, Maggie K. S. Tang, Zeyu Shi, Lin-Yu Chen, Hung-Cheng Lai, Zhenyu Yang, Ho-Cheung Shum, Alice S. T. Wong

    Publicat 2022-06-01
    Obtenir text complet
    Article
  5. 5
    Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report

    Complete remission of heavily treated ovarian clear cell carcinoma with ARID1A mutations after pembrolizumab and bevacizumab combination therapy: a case report per Yu-Chien Lin, Kuo-Chang Wen, Pi-Lin Sung, Yu-Ting Chou, Phui-Ly Liew, Lin-Yu Chen, Rui-Lan Huang, Hung-Cheng Lai, Lu-Te Chang

    Publicat 2020-12-01
    Obtenir text complet
    Article
  6. 6
    Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor

    Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor per Lin-Yu Chen, Yao-An Shen, Ling-Hui Chu, Po-Hsuan Su, Hui-Chen Wang, Yu-Chun Weng, Shiou-Fu Lin, Kuo-Chang Wen, Phui-Ly Liew, Hung-Cheng Lai

    Publicat 2024-06-01
    Obtenir text complet
    Article
  7. 7
    Correction: In vitro drug testing using patient-derived ovarian cancer organoids

    Correction: In vitro drug testing using patient-derived ovarian cancer organoids per Lin-Yu Chen, Yu-Ting Chou, Phui-Ly Liew, Ling-Hui Chu, Kuo-Chang Wen, Shiou-Fu Lin, Yu-Chun Weng, Hui-Chen Wang, Po-Hsuan Su, Hung-Cheng Lai

    Publicat 2024-12-01
    Obtenir text complet
    Article
  8. 8
    In vitro drug testing using patient-derived ovarian cancer organoids

    In vitro drug testing using patient-derived ovarian cancer organoids per Lin-Yu Chen, Yu-Ting Chou, Phui-Ly Liew, Ling-Hui Chu, Kuo-Chang Wen, Shiou-Fu Lin, Yu-Chun Weng, Hui-Chen Wang, Po-Hsuan Su, Hung-Cheng Lai

    Publicat 2024-10-01
    Obtenir text complet
    Article

Eines de cerca: